Literature DB >> 23043558

Roles of proteolysis in regulation of GPCR function.

G S Cottrell1.   

Abstract

The enzymatic activity of peptidases must be tightly regulated to prevent uncontrolled hydrolysis of peptide bonds, which could have devastating effects on biological systems. Peptidases are often generated as inactive propeptidases, secreted with endogenous inhibitors, or they are compartmentalized. Propeptidases become active after proteolytic removal of N-terminal activation peptides by other peptidases. Some peptidases only become active towards substrates only at certain pHs, thus confining activity to specific compartments or conditions. This review discusses the different roles proteolysis plays in regulating GPCRs. At the cell-surface, certain GPCRs are regulated by the hydrolytic inactivation of bioactive peptides by membrane-anchored peptidases, which prevent signalling. Conversely, cell-surface peptidases can also generate bioactive peptides, which directly activate GPCRs. Alternatively, cell-surface peptidases activated by GPCRs, can generate bioactive peptides to cause transactivation of receptor tyrosine kinases, thereby promoting signalling. Certain peptidases can signal directly to cells, by cleaving GPCR to initiate intracellular signalling cascades. Intracellular peptidases also regulate GPCRs; lysosomal peptidases destroy GPCRs in lysosomes to permanently terminate signalling and mediate down-regulation; endosomal peptidases cleave internalized peptide agonists to regulate GPCR recycling, resensitization and signalling; and soluble intracellular peptidases also participate in GPCR function by regulating the ubiquitination state of GPCRs, thereby altering GPCR signalling and fate. Although the use of peptidase inhibitors has already brought success in the treatment of diseases such as hypertension, the discovery of new regulatory mechanisms involving proteolysis that control GPCRs may provide additional targets to modulate dysregulated GPCR signalling in disease.
© 2012 The Author. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23043558      PMCID: PMC3579280          DOI: 10.1111/j.1476-5381.2012.02234.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  170 in total

1.  Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors.

Authors:  J C Reubi; W H Häcki; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

2.  Somatostatin receptors in human endocrine tumors.

Authors:  J C Reubi; R Maurer; K von Werder; J Torhorst; J G Klijn; S W Lamberts
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

3.  Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin.

Authors:  J M Lundberg; A Franco-Cereceda; X Hua; T Hökfelt; J A Fischer
Journal:  Eur J Pharmacol       Date:  1985-02-05       Impact factor: 4.432

4.  Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.

Authors:  S K Shenoy; P H McDonald; T A Kohout; R J Lefkowitz
Journal:  Science       Date:  2001-10-04       Impact factor: 47.728

5.  Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide.

Authors:  Y Kuraishi; T Nanayama; H Ohno; M Minami; M Satoh
Journal:  Neurosci Lett       Date:  1988-10-17       Impact factor: 3.046

6.  The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.

Authors:  R Matsas; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

7.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

8.  Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system.

Authors:  J C Reubi; W Lang; R Maurer; J W Koper; S W Lamberts
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

9.  Neurogenic inflammation in the rat trachea. I. Changes in venules, leucocytes and epithelial cells.

Authors:  D M McDonald
Journal:  J Neurocytol       Date:  1988-10

10.  Calcitonin gene-related peptide is a potent vasodilator.

Authors:  S D Brain; T J Williams; J R Tippins; H R Morris; I MacIntyre
Journal:  Nature       Date:  1985 Jan 3-9       Impact factor: 49.962

View more
  6 in total

1.  The background to this themed issue on neuropeptides.

Authors:  Julie Keeble
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Elastase-2 Knockout Mice Display Anxiogenic- and Antidepressant-Like Phenotype: Putative Role for BDNF Metabolism in Prefrontal Cortex.

Authors:  C R A F Diniz; C Becari; A Lesnikova; C Biojone; M C O Salgado; H C Salgado; L B M Resstel; F S Guimarães; E Castrén; P C Casarotto; S R L Joca
Journal:  Mol Neurobiol       Date:  2018-01-30       Impact factor: 5.590

Review 3.  Mechanisms and Regulation of Neuronal GABAB Receptor-Dependent Signaling.

Authors:  Timothy R Rose; Kevin Wickman
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 4.  Novel Structural Approaches to Study GPCR Regulation.

Authors:  Marco A Alfonzo-Méndez; Rocío Alcántara-Hernández; J Adolfo García-Sáinz
Journal:  Int J Mol Sci       Date:  2016-12-23       Impact factor: 5.923

5.  Proteolysis of histidine kinase VgrS inhibits its autophosphorylation and promotes osmostress resistance in Xanthomonas campestris.

Authors:  Chao-Ying Deng; Huan Zhang; Yao Wu; Li-Li Ding; Yue Pan; Shu-Tao Sun; Ya-Jun Li; Li Wang; Wei Qian
Journal:  Nat Commun       Date:  2018-11-15       Impact factor: 14.919

6.  The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases.

Authors:  James L J Coleman; Tony Ngo; Rhyll E Smythe; Andrew J Cleave; Nicole M Jones; Robert M Graham; Nicola J Smith
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.